|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B in Interleukin-1
-induced VCAM-1 Expression in Human Tracheal Smooth Muscle Cells
1 Graduate Institute of natrual Products, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
2 Department of Pharmacology, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
3 Department of Anesthetics, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
4 Department of Internal Medicine, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
5 Graduate Institute of rehabilitation Asicence, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
6 Graduate Institute of natrual Products, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan; Department of Pharmacology, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan
* To whom correspondence should be addressed. E-mail: chuenmao{at}mail.cgu.edu.tw.
Interleukin-1
(IL-1
) has been shown to induce the expression of adhesion molecules on airway epithelial and smooth cells and contributes to inflammatory
responses. Here, the roles of mitogen-activated protein kinases (MAPKs) and nuclear factor-
B (NF-
B) pathways for IL-1
-induced vascular cell adhesion molecule (VCAM)-1 expression were investigated in human tracheal smooth muscle cells (HTSMC). IL-1
induced expression of VCAM-1 protein and mRNA in a time-dependent manner, which was significantly inhibited by inhibitors of MEK1/2 (U0126 and PD98059), p38 (SB202190), and c-Jun-N-terminal kinase (JNK; SP600125). Consistently, IL-1
-stimulated phosphorylation of p42/p44 MAPK, p38,
and JNK was attenuated by pretreatment with U0126, SB202190, or SP600125, respectively. IL-1
-induced VCAM-1 expression was significantly blocked by
specific NF-
B inhibitors helenalin and PDTC. As expected, IL-1
-stimulated translocation of NF-
B into the nucleus and degradation of I
B-
was blocked by helenalin, but not by U0126, SB202190, or SP600125. Moreover, the resultant enhancement of VCAM-1 expression increased the adhesion of polymorphonuclear cells to monolayer of HTSMC which was blocked by pretreatment with helenalin, U0126, SB202190, or SP600125 prior to IL-1
exposure or by anti-VCAM-1 antibody. Taken together, these results suggest that in HTSMC, activation of p42/p44 MAPK, p38, JNK and NF-
B pathways is essential for IL-1
-induced VCAM-1 gene
expression. These results provide new insight into the mechanisms of IL-1
action that cytokines may promote inflammatory responses in the airway disease.
This article has been cited by other articles:
![]() |
B. N. Kang, J. A. Jude, R. A. Panettieri Jr., T. F. Walseth, and M. S. Kannan Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1 Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L186 - L193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Lee, C.-C. Lin, S.-F. Luo, H.-C. Lee, I.-T. Lee, W. C. Aird, T.-L. Hwang, and C.-M. Yang Tumor Necrosis Factor-{alpha} Enhances Neutrophil Adhesiveness: Induction of Vascular Cell Adhesion Molecule-1 via Activation of Akt and CaM Kinase II and Modifications of Histone Acetyltransferase and Histone Deacetylase 4 in Human Tracheal Smooth Muscle Cells Mol. Pharmacol., May 1, 2008; 73(5): 1454 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Tirumurugaan, J. A. Jude, B. N. Kang, R. A. Panettieri, T. F. Walseth, and M. S. Kannan TNF-{alpha} induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-{kappa}B and AP-1 Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1385 - L1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Issa, S. Xie, K.-Y. Lee, R. D. Stanbridge, P. Bhavsar, M. B. Sukkar, and K. F. Chung GRO-{alpha} regulation in airway smooth muscle by IL-1beta and TNF-{alpha}: role of NF-{kappa}B and MAP kinases Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L66 - L74. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |